ProQR Therapeutics N.V. (PRQR) Tops Q1 EPS by 1c

ProQR Therapeutics N.V. (NASDAQ: PRQR) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.45 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on ProQR Therapeutics N.V. (PRQR) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• DAM Capital Starts Centum Electronics (CTE:IN) at Buy
• JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral